Expression of BIRC7 protein and mRNA in non-Hodgkin's lymphoma

References

• LaCasse E C, Baird S, Korneluk R G, MacKenzie A E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998; 17: 3247–3259
   PubMed Web of Science ®Google Scholar
• Clem R J, Sheu T T, Richter B W, He W W, Thornberry N A, Duckett C S, Hardwick J M. c-IAP1 is cleaved by caspases to produce a proapoptotic C-terminal fragment. J Biol Chem 2001; 276: 7602–7608
   PubMed Web of Science ®Google Scholar
• Ueda T, Akiyama N, Sai H, Oya N, Noda M, Hiraoka M, Kizaka-Kondoh. c-IAP2 is induced by ionizing radiation through NF-kappaB binding sites. FEBS Lett 2001; 491: 40–44
   PubMed Web of Science ®Google Scholar
• Young S S, Liston P, Xuan J Y, McRoberts C, Lefebvre C A, Korneluk R G. Genomic organization and physical map of the human inhibitors of apoptosis: HIAP1 and HIAP2. Mamm Genome 1999; 10: 44–48
   PubMed Web of Science ®Google Scholar
• Ikeda J. Neuronal apoptosis inhibitory protein NAIP and its related nerve degenerate disorder. Nippon Ika Daigaku Zasshi 1997; 64: 471–474
   PubMedGoogle Scholar
• Ambrosini G, Adida C, Altieri D C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917–921
   PubMed Web of Science ®Google Scholar
• Shinozawa I, Inokuchi K, Wakabayashi I, Dan K. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies. Leuk Res 2000; 24: 965–970
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Nakabayashi Y, Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci USA 2001; 98: 8662–8667
   PubMed Web of Science ®Google Scholar
• Qiu X B, Goldberg A L. The membrane-associated inhibitor of apoptosis protein, BRUCE/Apollon, antagonizes both the precursor and mature forms of Smac and caspase-9. J Biol Chem 2005; 280: 174–182
   PubMed Web of Science ®Google Scholar
• Richter B W, Mir S S, Eiben L J, Lewis J, Reffey S B, Frattini A, et al. Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family. Mol Cell Biol 2001; 21: 4292–4301
   PubMed Web of Science ®Google Scholar
• Ashhab Y, Alian A, Polliack A, Panet A, Ben Yehuda D. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett 2001; 495: 56–60
   PubMed Web of Science ®Google Scholar
• Kasof G M, Gomes B C. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 2001; 276: 3238–3246
   PubMed Web of Science ®Google Scholar
• Lin J H, Deng G, Huang Q, Morser J. KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun 2000; 279: 820–831
   PubMed Web of Science ®Google Scholar
• Vucic D, Stennicke H R, Pisabarro M T, Salvesen G S, Dixit V M. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 2000; 10: 1359–1366
   PubMed Web of Science ®Google Scholar
• Gazzaniga P, Gradilone A, Giuliani L, Gandini O, Silvestri I, Nofroni I, et al. Expression and prognostic significance of livin, survivin and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 2003; 14: 85–90
   PubMed Web of Science ®Google Scholar
• Muller A M, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005; 84: 1–12
   PubMed Web of Science ®Google Scholar
• Canellos G P. Lymphoma: present and future challenges. Semin Hematol 2004; 41(Suppl 7)26–31
   PubMed Web of Science ®Google Scholar
• Gu Xia, Lin Hanliang, Shen Yan, Ru Jingshun, Zhou Wei, Sun Yi. Expression and significance of survivin and bcl-2 in lymphomas. J Clin Exp Pathol 2005; 21: 159–163
   Google Scholar
• Ansell S M, Arendt B K, Grote D M, Jelinek D F, Novak A J, Wellik L E, et al. Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. Leukemia 2004; 18: 616–623
   PubMed Web of Science ®Google Scholar
• Schlette E J, Medeiros L J, Goy A, Lai R, Rassidakis G Z. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol 2004; 22: 1682–1688
   PubMed Web of Science ®Google Scholar
• Nachmias B, Ashhab Y, Ben-Yehuda D. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol 2004; 14: 231–243
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Stein H, Vardiman J W. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumours. IARC Press, LyonFrance 2001
   Google Scholar
• Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844–847
   PubMed Web of Science ®Google Scholar
• Pileri S A, Ascani S, Sabattini E, Fraternali-Orcioni G, Poggi S, Piccioli M, et al. The pathologist's view point. Part II – aggressive lymphomas. Haematologica 2000; 85: 1308–1321
   PubMed Web of Science ®Google Scholar
• Kutok J L, Aster J C. Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma. J Clin Oncol 2002; 20: 3691–3702
   PubMed Web of Science ®Google Scholar
• Sun J G, Liao R X, Chen Z T, Wang Z X, Zhang Q, Wu W L. Expression of Livin, a novel inhibitor of apoptosis protein family member, in tissues of non-small cell lung cancer. Chongqing Med J 2004; 33: 982–984
   Google Scholar
• Yagihashi A, Asanuma K, Tsuji N, Torigoe T, Sato N, Hirata K, Watanabe N. Detection of anti-livin antibody in gastrointestinal cancer patients. Clin Chem 2003; 49: 1206–1208
   PubMed Web of Science ®Google Scholar
• Yagihashi A, Ohmura T, Asanuma K, Kobayashi D, Tsuji N, Torigoe T, et al. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer. Clin Chim Acta 2005; 362: 125–130
   PubMed Web of Science ®Google Scholar
• Tanabe H, Yagihashi A, Tsuji N, Shijubo V, Abe S, Watanabe N. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer. Lung Cancer 2004; 46: 299–304
   PubMed Web of Science ®Google Scholar
• Conway E M, Pollefeyt S, Cornelissen J, DeBaere I, Steiner-Mosonyi M, Ong K, et al. Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions. Blood 2000; 95: 1435–1442
   PubMed Web of Science ®Google Scholar
• Sanna M G, da Silva Correia J, Ducrey O, Lee J, Nomoto K, Schrantz N, et al. IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition. Mol Cell Biol 2002; 22: 1754–1766
   PubMed Web of Science ®Google Scholar
• Vucic D, Deshayes K, Ackerly H, Pisabarro M T, Kadkhodayan S, Fairbrother W J, Dixit V M. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP). J Biol Chem 2002; 277: 12275–12279
   PubMed Web of Science ®Google Scholar
• Yang Q H, Church-Hajduk R, Ren J, Newton M L, Du C. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev 2003; 17: 1487–1496
   PubMed Web of Science ®Google Scholar
• Krasznai Z T, Friedlander E, Nagy A, Szabo G, Vereb G, Goda K, Hernadi Z. Quantitative and functional assay of MDR1/P170-mediated MDR in ascites cells of patients with ovarian cancer. Anticancer Res 2005; 25: 1187–1192
   PubMed Web of Science ®Google Scholar
• Nachmias B, Ashhab Y, Bucholtz V, Drize O, Kadouri L, Lotem M, et al. Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma. Cancer Res 2003; 63: 6340–6349
   Google Scholar
• Qiuping Z, Jei X, Youxin J, Wei J, Chun L, Jin W, et al. CC chemokine ligand 25 enhances resistance to apoptosis in CD4 + T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation. Cancer Res 2004; 64: 7579–7587
   PubMed Web of Science ®Google Scholar